TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer

Overview of attention for article published in Cancer Discovery, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,321 followers.

RT @ElizSMcKenna: Now online in @CD_AACR: TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for…

RT @ElizSMcKenna: Now online in @CD_AACR: TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for…

RT @ElizSMcKenna: Now online in @CD_AACR: TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for…

RT @ElizSMcKenna: Now online in @CD_AACR: TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.